Left Main Disease

Jinho Lee; Duk-Woo Park; Seung-Jung Park

doi:10.1016/j.iccl.2022.02.006

Left Main Disease

Interv Cardiol Clin. 2022 Oct;11(4):359-371. doi: 10.1016/j.iccl.2022.02.006. Epub 2022 Sep 24.

Authors

Jinho Lee¹, Duk-Woo Park², Seung-Jung Park³

Affiliations

¹ Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea.
² Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea. Electronic address: [email protected].
³ Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea. Electronic address: [email protected].

PMID: 36243482
DOI: 10.1016/j.iccl.2022.02.006

Abstract

Traditionally, the treatment of left main coronary artery disease is recommended coronary artery bypass grafting because of its superior long-term outcomes compared with medical treatment and plain old balloon angioplasty. However, improvement of percutaneous coronary intervention technique and introduction of drug-eluting stent led to change of treatment strategy of left main coronary artery disease through cumulative data for revascularization that based on clinical evidence.

Keywords: Coronary artery bypass surgery; Left main coronary artery disease; Percutaneous coronary intervention; Revascularization strategy.

Publication types

Review

MeSH terms

Coronary Artery Disease* / surgery
Drug-Eluting Stents*
Humans
Risk Factors
Time Factors
Treatment Outcome